Amedisys, Inc. (AMED) Misses Q2 EPS by 1c; Cuts FY11 Outlook
Tweet Send to a FriendGet Alerts AMED Hot Sheet
Price: $11.10 +0.45%
EPS Growth %: -12.0%
Financial Fact:
Miscellaneous, net: 59K
Today's EPS Names:
CSS, STV, GIGM, More
EPS Growth %: -12.0%
Financial Fact:
Miscellaneous, net: 59K
Today's EPS Names:
CSS, STV, GIGM, More
Trade AMED Now!
Amedisys, Inc. (NASDAQ: AMED) reported Q2 EPS of $0.67, $0.01 worse than the analyst estimate of $0.68. Revenue for the quarter came in at $373.7 million versus the consensus estimate of $383.21 million.
Amedisys, Inc. sees FY2011 EPS of $2.20-$2.40, versus the consensus of $2.94. Prior guidance was for $3.00-$3.30. Amedisys, Inc. sees FY2011 revenue of $1.475-$1.5 billion, versus the consensus of $1.58 billion.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Amedisys, Inc. sees FY2011 EPS of $2.20-$2.40, versus the consensus of $2.94. Prior guidance was for $3.00-$3.30. Amedisys, Inc. sees FY2011 revenue of $1.475-$1.5 billion, versus the consensus of $1.58 billion.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- NetApp (NTAP) Tops Q4 EPS by 1c; Boosts Buyback, Plans Job Cuts, Initiates Dividend
- Natus Medical (BABY) Tops Q1 EPS by 4c; Nudges FY13 EPS Outlook Higher
- Campbell Soup Co. (CPB) Tops Q3 EPS by 6c; Boosts FY13 Outlook
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Hot Guidance, Trading Halts
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
